Scientists at Texas A&M University have created a system where caffeine can switch on gene-editing in engineered cells. Using CRISPR and “caffebodies,” cells can be activated by coffee, chocolate, or soda to target cancer or regulate insulin for diabetes. Rapamycin can act as an off-switch, making the therapy controllable. This approach may allow simple everyday compounds to guide advanced treatments safely.
